ROMAN
PEREZ FERNANDEZ
Catedrático de universidade
Juan José
Sendón Lago
Publicacións nas que colabora con Juan José Sendón Lago (13)
2022
-
Conditioned Medium from Human Uterine Cervical Stem Cells Regulates Oxidative Stress and Angiogenesis of Retinal Pigment Epithelial Cells
Ophthalmic research, Vol. 65, Núm. 5, pp. 556-565
-
In Vivo Effects of Conditioned Medium from Human Uterine Cervical Stem Cells in an Ovarian Cancer Xenograft Mouse Model
Cancer genomics & proteomics, Vol. 19, Núm. 5, pp. 570-575
2021
2019
-
Corneal regeneration by conditioned medium of human uterine cervical stem cells is mediated by TIMP-1 and TIMP-2
Experimental Eye Research, Vol. 180, pp. 110-121
2018
-
Breast cancer metastasis to liver and lung is facilitated by Pit-1-CXCL12-CXCR4 axis
Oncogene, Vol. 37, Núm. 11, pp. 1430-1444
2017
2016
-
Anti-inflammatory effect of conditioned medium from human uterine cervical stem cells in uveitis
Experimental Eye Research, Vol. 149, pp. 84-92
2015
-
Corneal epithelial wound healing and bactericidal effect of conditioned medium from human uterine cervical stem cells
Investigative Ophthalmology and Visual Science, Vol. 56, Núm. 2, pp. 983-992
-
Pit-1 inhibits BRCA1 and sensitizes human breast tumors to cisplatin and vitamin D treatment
Oncotarget, Vol. 6, Núm. 16, pp. 14456-14471
2014
-
26,26,26,27,27,27-hexadeuterated-1,25-dihydroxyvitamin D3 (1,25D-d6) as adjuvant of chemotherapy in breast cancer cell lines
Cancers, Vol. 6, Núm. 1, pp. 67-78
-
Cancer progression by breast tumors with Pit-1-overexpression is blocked by inhibition of metalloproteinase (MMP)-13
Breast Cancer Research, Vol. 16, Núm. 1
-
Potential therapeutic effect of the secretome from human uterine cervical stem cells against both cancer and stromal cells compared with adipose tissue stem cells
Oncotarget, Vol. 5, Núm. 21, pp. 10692-10708
2013
-
Administration of the optimized β-Lapachone-poloxamer-cyclodextrin ternary system induces apoptosis, DNA damage and reduces tumor growth in a human breast adenocarcinoma xenograft mouse model
European Journal of Pharmaceutics and Biopharmaceutics, Vol. 84, Núm. 3, pp. 497-504